| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/07/2001 | US6271444 Enhancer elements for increased translation in plant plastids |
| 08/07/2001 | US6271443 Cotton and rice cellulose synthase DNA sequences |
| 08/07/2001 | US6271442 Nucleotide sequences coding protein for use in the development of disease resistant plants and animals; for use in the treatment of disease in animals and plants |
| 08/07/2001 | US6271440 Plant regulatory proteins III |
| 08/07/2001 | US6271436 Cells and methods for the generation of transgenic pigs |
| 08/07/2001 | US6271435 Leukotriene B4 receptor transgenic mice |
| 08/07/2001 | US6271381 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 08/07/2001 | US6271365 Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them |
| 08/07/2001 | US6271363 Nucleotide sequences coding morphology determining polypeptides; for diagnosis and treatment of cell proliferation and differentiation defects; for treatment of urogenital and osteogenic defects |
| 08/07/2001 | US6271361 Nucleotide sequences coding an enzymatic polypeptide; for the treatment of autoimmune and viral diseases, tumors and nervous system disorders |
| 08/07/2001 | US6271360 Single-stranded oligodeoxynucleotide mutational vectors |
| 08/07/2001 | US6271341 Fusion protein associated with the control of gene expression; for use as a tool in controlled gene expression |
| 08/07/2001 | US6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 08/07/2001 | US6271201 Methods for the selective regulation of placental prostanoids and inhibition of labor using IGF-I |
| 08/07/2001 | US6271197 Administering a geranylgeranyl transferase inhibitor |
| 08/07/2001 | US6271196 Polypeptide |
| 08/07/2001 | US6271032 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid |
| 08/07/2001 | US6271031 Nucleic acid fragments encoding enzymes involved in quinolinate metabolism in plants and seeds |
| 08/07/2001 | US6271030 For modulation of c/ebp beta (transcription factor enhancer-binding gene) expression and for treatment of diseases associated with expression of c/ebp beta |
| 08/07/2001 | US6271028 Hematopoietic cell method for treatment of HIV infection |
| 08/07/2001 | US6271027 Cell and tissue culture device with enhanced culture fluid flow |
| 08/07/2001 | US6271026 Nucleotide sequences coding protein associated with vision defects; for the diagnsis and treatment of preferential vision defects |
| 08/07/2001 | US6271025 Modified factor VIII cDNA |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6271018 Muskmelon (Cucumis melo) hydroperoxide lyase and uses thereof |
| 08/07/2001 | US6271016 A dna molecule encoding a corn synthase that is resistant to inhibition by free l-tryptophan; genetically regulating plant growth |
| 08/07/2001 | US6271014 A polypeptide with proteolytic activity; therapy for periodontal disease, rheumatoid arthritis, aging, cancer, wound healing, bone resorption, pregnancy and parturition |
| 08/07/2001 | US6270996 Enhancing conversion of single stranded adeno-associated virus to double stranded; infecting target cells with the recombinant virus and exposing the infected cells to an agent; gene therapy cancer and cystic fibrosis |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270993 VEGF-binding polypeptide |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270989 A homologous recombinant dna construct comprising a targeting sequence, an exogenous regulatory sequence, an exon and an unpaired splice donor site at the 3'end; gene therapy for thrombopoietin, thrombocytopenia, multiple sclerosis |
| 08/07/2001 | US6270987 Glycosylating an epidermal growth factor domain of a polypeptide with an activated o-frucose; cancer diagnosis |
| 08/07/2001 | US6270969 Recombinational cloning using engineered recombination sites |
| 08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
| 08/07/2001 | US6270958 Detection of negative-strand RNA viruses |
| 08/07/2001 | US6270956 Polypeptide activator of gene expression; for use in treatment of preferential viral diseases and infections; for the detection of modulators of gene expression |
| 08/07/2001 | US6270952 Methods for quenching pathogen inactivators in biological materials |
| 08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
| 08/07/2001 | US6270772 Mhc class ii based molecules that comprise covalently linked beta 1 and alpha 1 domains, and mhc class i based molecules that comprise covalently linked alpha 1 and alpha 2 domains. |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | CA2051659C Platelet membrane microparticles |
| 08/07/2001 | CA1341280C Non-human carbonyl hydrolase mutants, dna sequences and vectors encoding same and hosts transformed with said vectors |
| 08/02/2001 | WO2001055440A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055432A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 08/02/2001 | WO2001055388A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055361A2 Recombinant aav packaging systems |
| 08/02/2001 | WO2001055358A2 Phosphodiesterases |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055349A1 Modulation of tolerance by altering nfat signalling |
| 08/02/2001 | WO2001055348A1 Improved inhibition of graft versus host disease |
| 08/02/2001 | WO2001055346A2 System for the internal qualitative and quantitative validation of marker indices |
| 08/02/2001 | WO2001055345A2 Method for producing a serum-containing culture medium for cells and the use thereof |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055329A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055306A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055297A2 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
| 08/02/2001 | WO2001055216A1 Methods and compositions for generating human monoclonal antibodies |
| 08/02/2001 | WO2001055212A2 Delivery of therapeutic biological from implantable tissue matrices |
| 08/02/2001 | WO2001055211A2 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | WO2001055210A2 Human cyr61 |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055103A2 Chimeric neuropeptide y receptors |
| 08/02/2001 | WO2001054619A1 Tissue graft |
| 08/02/2001 | WO2001054487A1 Novel 'oxy' cms brassica napus plant corrected for chlorosis using hexaploid bridging material generated through protoplast fusion |
| 08/02/2001 | WO2001018048A3 Smooth muscle cell promoter and uses thereof |
| 08/02/2001 | WO2001016303A3 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001013932A3 Stimulation of sperm function |
| 08/02/2001 | WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 08/02/2001 | WO2001005950A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | WO2001005826A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001004144A3 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 08/02/2001 | WO2001002592A9 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2001000804A3 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 08/02/2001 | WO2000070036A3 Genes expressed in hippocampus |
| 08/02/2001 | WO2000069898A3 Molecular interactions in allergy cells |
| 08/02/2001 | WO2000065070A9 Cell culture process for glycoproteins |
| 08/02/2001 | WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO2000026241A9 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/02/2001 | WO2000023602A3 Regulated expression using conditional er retention domains |
| 08/02/2001 | WO1999049025A3 Human vault rna |
| 08/02/2001 | US20010011381 Genetic engineering |
| 08/02/2001 | US20010011380 Administering drugs comprising kunitzt type inhibitors as antiedemic, anticoagulant, antiischemic or antiinflammatory agents |
| 08/02/2001 | US20010011379 Mutant which interfers with virus reproduction during infection |
| 08/02/2001 | US20010011378 Isotype of starch synthase |
| 08/02/2001 | US20010011377 Adjustment of seed protein profile |
| 08/02/2001 | US20010011126 Isolated protein; genetic engineering |
| 08/02/2001 | US20010011124 Genetic engineering |